Baudax Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017
Net Income	-58.8	-19.77	-76.1	-32.56	-73.67	Upgrade
Depreciation & Amortization	2.16	2.82	2.55	0.48	0.4	Upgrade
Share-Based Compensation	1.4	4.79	9.34	5.46	4.57	Upgrade
Other Operating Activities	27.44	-37.11	20.15	-23.43	8.95	Upgrade
Operating Cash Flow	-27.79	-49.27	-44.06	-50.04	-59.75	Upgrade
Capital Expenditures	-0.02	-0.2	-0.64	-1.48	-3.45	Upgrade
Change in Investments	0	0.01	0	0	0	Upgrade
Investing Cash Flow	-0.02	-0.19	-0.64	-1.48	-3.45	Upgrade
Share Issuance / Repurchase	20.83	42.88	50.82	0	0	Upgrade
Debt Issued / Paid	-2.45	0	10.04	0	0	Upgrade
Other Financing Activities	-1.2	-7.87	-3.56	69.27	63.2	Upgrade
Financing Cash Flow	17.18	35.01	57.3	69.27	63.2	Upgrade
Net Cash Flow	-10.63	-14.45	12.6	17.74	0	Upgrade
Free Cash Flow	-27.81	-49.47	-44.7	-51.53	-63.2	Upgrade
Free Cash Flow Margin	-2191.73%	-4580.83%	-9066.33%	-	-	Upgrade
Free Cash Flow Per Share	-83.87	-903.82	-3356.64	-7714.85	-9462.84	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).